Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results

Eur J Surg Oncol. 2019 Oct;45(10):1993-1999. doi: 10.1016/j.ejso.2019.07.018. Epub 2019 Jul 16.

Abstract

Purpose: This study sought to identify factors associated with survival of pT1 urothelial carcinoma of bladder (UCB) after radical cystectomy (RC).

Methods: This study consists of 114 pT1 UCB [primary 83, recurrent 31, none were amenable to transurethral resection (TUR)] treated by radical cystectomy. Survival analysis using Cox regression tests were performed to identify factors associated with survival of pT1 UCB after RC.

Results: Pelvic lymph node (LN) status, age and lymphovascular invasion (LVI) are associated with survival of pT1 UCB after RC; recurrent pT1 UCB of high grade origin (HGO) tends to have poorer CSS than primary pT1 UCB or recurrent pT1 UCB of low grade origin (LGO) (5-year and 10-year CSS rates was 75% and 73% for primary cases; 77% and 77% for recurrent pT1 UCB of LGO; and 56% and 37% for recurrent pT1 UCB of HGO, p = 0.078).

Conclusions: LN status, age and LVI were significantly associated with survival of pT1 UCB after RC. Recurrent pT1 UCB of HGO should be managed with radical cystectomy in a timely fashion given that these cases tend to have poorer CSS than primary pT1 UCB after RC, even if they did not progress to muscle-invasive bladder cancer (MIBC).

Keywords: Lymphovascular invasion; Non-muscle-invasive bladder cancer; Outcome; Radical cystectomy.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Transitional Cell / mortality
  • Carcinoma, Transitional Cell / secondary
  • Carcinoma, Transitional Cell / surgery*
  • China / epidemiology
  • Cystectomy / methods*
  • Cystoscopy / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging*
  • Postoperative Period
  • Prognosis
  • Retrospective Studies
  • Survival Rate / trends
  • Time Factors
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / surgery*